These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25290986)

  • 21. High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.
    Cunha PP; Costa PM; Morais CM; Lopes IR; Cardoso AM; Cardoso AL; Mano M; Jurado AS; Pedroso de Lima MC
    Hum Mol Genet; 2017 Nov; 26(22):4375-4387. PubMed ID: 28973155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.
    Alafate W; Xu D; Wu W; Xiang J; Ma X; Xie W; Bai X; Wang M; Wang J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):239. PubMed ID: 33176854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.
    Yang F; Nam S; Brown CE; Zhao R; Starr R; Ma Y; Xie J; Horne DA; Malkas LH; Jove R; Hickey RJ
    PLoS One; 2014; 9(4):e94443. PubMed ID: 24732116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma.
    Nadeem Abbas M; Kausar S; Wang F; Zhao Y; Cui H
    Cells; 2019 Apr; 8(4):. PubMed ID: 31013819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
    Tian T; Mingyi M; Qiu X; Qiu Y
    Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations.
    Abbas MN; Kausar S; Cui H
    Clin Transl Oncol; 2020 Jul; 22(7):963-977. PubMed ID: 31630356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels.
    Bozdag S; Li A; Riddick G; Kotliarov Y; Baysan M; Iwamoto FM; Cam MC; Kotliarova S; Fine HA
    PLoS One; 2013; 8(4):e62982. PubMed ID: 23658659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme.
    González-Gómez P; Sánchez P; Mira H
    Mol Neurobiol; 2011 Dec; 44(3):235-49. PubMed ID: 21728042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
    Mao H; Lebrun DG; Yang J; Zhu VF; Li M
    Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Importance of Mutational Drivers in GBM.
    Kalkan R
    Crit Rev Eukaryot Gene Expr; 2016; 26(1):19-26. PubMed ID: 27278882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying the miRNA Signature Association with Aging-Related Senescence in Glioblastoma.
    Gnanavel M; Murugesan A; Konda Mani S; Yli-Harja O; Kandhavelu M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M
    Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translating biology into clinic: the case of glioblastoma.
    Lino M; Merlo A
    Curr Opin Cell Biol; 2009 Apr; 21(2):311-6. PubMed ID: 19217766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
    Costa PM; Cardoso AL; Nóbrega C; Pereira de Almeida LF; Bruce JN; Canoll P; Pedroso de Lima MC
    Hum Mol Genet; 2013 Mar; 22(5):904-18. PubMed ID: 23201752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic regulation of the miR142-3p/interleukin-6 circuit in glioblastoma.
    Chiou GY; Chien CS; Wang ML; Chen MT; Yang YP; Yu YL; Chien Y; Chang YC; Shen CC; Chio CC; Lu KH; Ma HI; Chen KH; Liu DM; Miller SA; Chen YW; Huang PI; Shih YH; Hung MC; Chiou SH
    Mol Cell; 2013 Dec; 52(5):693-706. PubMed ID: 24332177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme.
    El Hindy N; Keyvani K; Pagenstecher A; Dammann P; Sandalcioglu IE; Sure U; Zhu Y
    Neuro Oncol; 2013 Oct; 15(10):1366-78. PubMed ID: 23787764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
    Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
    Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.